Kathleen K Schoemaker's Net Worth
$328 Million
Who is Kathleen K Schoemaker?
Kathleen K Schoemaker has an estimated net worth of $328 Million. This is based on reported shares across multiple companies, which include CoLucid Pharmaceuticals, Inc., MARINUS PHARMACEUTICALS INC, GLAUKOS Corp, Atara Biotherapeutics, Inc., Aldeyra Therapeutics, Inc., aTYR PHARMA INC, OTONOMY, INC., Neothetics, Inc., Durata Therapeutics, Inc., CADENCE PHARMACEUTICALS INC, Regado Biosciences Inc, Esperion Therapeutics, Inc., Clovis Oncology, Inc., ALIMERA SCIENCES INC, Evoke Pharma Inc, VERACYTE, INC., Dicerna Pharmaceuticals Inc, Volcano Corp, Orexigen Therapeutics, Inc., ZOGENIX, INC., Northstar Neuroscience, Inc., INTRALASE CORP, IOMAI CORP, TANDEM DIABETES CARE INC, Vanda Pharmaceuticals Inc., NUVASIVE INC, Transcept Pharmaceuticals Inc, REVA Medical, Inc., SENOMYX INC, Ocera Therapeutics, Inc., Achaogen Inc, ACHILLION PHARMACEUTICALS INC, Celator Pharmaceuticals Inc, SANTARUS INC, Somaxon Pharmaceuticals, Inc., and SENORX INC.
SEC CIK
Kathleen K Schoemaker's CIK is 0001207789
Past Insider Trading and Trends
2010 was Kathleen K Schoemaker's most active year for acquiring shares with 36 total transactions. Kathleen K Schoemaker's most active month to acquire stocks was the month of October. 2014 was Kathleen K Schoemaker's most active year for disposing of shares, totalling 74 transactions. Kathleen K Schoemaker's most active month to dispose stocks was the month of October. 2011 saw Kathleen K Schoemaker paying a total of $26,590,082.18 for 7,499,108 shares, this is the most they've acquired in one year. In 2006 Kathleen K Schoemaker cashed out on 30,652,100 shares for a total of $51,028,309.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CoLucid Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.52K |
—
|
—
| 3.52K |
May 11
| |||
Form 4
| +5,043.01% | 2.2M |
—
|
—
| 2.25M |
May 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
MARINUS PHARMACEUTICALS INC (MRNS) Snapshot price: $9.945
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 17K |
—
|
—
| 17K |
Aug 5
| |||
Form 4
|
∞
| 2.48M |
$8.00 | $3,357,952.00 | 2.48M |
Aug 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
GLAUKOS Corp (GKOS) Snapshot price: $94.73
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 876.08K |
—
|
—
| 876.08K |
Jun 30
| |||
Form 4
|
∞
| 6.5K |
—
|
—
| 6.5K |
Jun 30
| |||
Form 4
|
∞
| 2.07M |
$12.83 | -$156,600.00 | 2.07M |
Jun 30
| |||
Form 4
|
∞
| 14.04K |
—
|
—
| 14.04K |
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Atara Biotherapeutics, Inc. (ATRA) Snapshot price: $1.06
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 15.89K |
$11.00 |
—
| 15.89K |
Oct 21
| |||
Form 4
|
∞
| 2.14M |
$11.00 |
—
| 2.14M |
Oct 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Aldeyra Therapeutics, Inc. (ALDX) Snapshot price: $3.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.09% | 21.25K |
—
|
—
| 1.97M |
May 7
| |||
Form 4
|
∞
| 9.21K |
—
|
—
| 9.21K |
May 1
| |||
Form 4
|
∞
| 1.95M |
$6.58 | $136.32 | 1.95M |
May 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |